SCHEMBL8935972

SCHEMBL8935972

CCCC1CC=C(c2ccc(-c3ccc(-c4ccc(OC)c(F)c4F)cc3)c(F)c2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.36
CCNT1 O60563 6/20 0.35
CDK9 P50750 6/20 0.35
PDE5A O76074 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
NAAA Q02083 3/20 0.32
ABCB1 P08183 2/20 0.32
PTGS2 P35354 2/20 0.32
MMP2 P08253 1/20 0.32
MMP3 P08254 1/20 0.32
PTGS1 P23219 1/20 0.31
NPC1 O15118 1/20 0.31
CASP3 P42574 1/20 0.31
RAB9A P51151 1/20 0.31
SENP8 Q96LD8 1/20 0.31
NLRP3 Q96P20 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
GRIN1 Q05586 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8936247 0.93 ESR2 (0.34) ESR2CCNT1CDK9PDE5AHDAC1
SCHEMBL8937308 0.93 NAAA (0.36) ESR2CCNT1CDK9NAAAPTGS2
SCHEMBL8936340 0.92 MGLL (0.33) ESR2CCNT1CDK9PDE5AHDAC1
SCHEMBL8932613 0.92 PDE5A (0.38) ESR2CCNT1CDK9PDE5AHDAC1
SCHEMBL8938718 0.90 ESR2 (0.36) ESR2CCNT1CDK9PDE5AHDAC1
SCHEMBL8936113 0.90 ESR2 (0.34) ESR2CCNT1CDK9PDE5AHDAC1
SCHEMBL8963542 0.89 CCNT1 (0.32) CCNT1CDK9NAAAMMP2MMP3
SCHEMBL8936046 0.89 ESR2 (0.34) ESR2CCNT1CDK9PDE5AHDAC1
SCHEMBL8937060 0.88 CCNT1 (0.34) ESR2CCNT1CDK9NAAAABCB1
SCHEMBL8936142 0.88 ESR2 (0.33) ESR2CCNT1CDK9PDE5AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8187494-B2 Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-05-29 US disclosed
US-8187494-B2 Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-05-29 US disclosed
US-20100309402-A1 FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100309402-A1 FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE KIF23, HCN3, FZD7 ESR2 2689/4885CCNT1 946/4885CDK9 775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.